Evidence map›Paper›PMID 19709900›Full record

ReviewTrends in endocrinology and metabolism: TEM2009

Endocrine disruptors in female reproductive tract development and carcinogenesis.

Liang Ma

Abstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Are the Effects of DES Over? A Tragic Lesson from the Past.International journal of environmental research and public health · 2021
    Review
  7. Article
  8. Article
  9. Animal models of endocrine disruption.Best practice & research. Clinical endocrinology & metabolism · 2018
    Review
  10. DNA methylation and transcriptome aberrations mediated by ERα in mouse seminal vesicles following developmental DES exposure.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Liang MaDivision of Dermatology, Department of Medicine and Department of Developmental Biology Washington University, St. Louis, MO 63110, USA. lima@dom.wustl.edu
Washington University in St. Louis · US

Funding

DES and the Regulation of the Uterine CytodifferentiationR01ES014482 · NIEHS · WASHINGTON UNIVERSITY · PI MA, LIANG · 2006 to 2010
$1.8M
NIEHS NIH HHS ES014482NIEHS NIH HHS R01 ES014482
6 · The paper itself

Abstract

Growing concerns over endocrine disrupting chemicals (EDCs) and their effects on human fetal development and adult health have promoted research into the underlying molecular mechanisms of endocrine disruption. Gene targeting technology has allowed insight into the genetic pathways governing reproductive tract development and how exposure to EDCs during a critical developmental window can alter reproductive tract development, potentially forming the basis for adult diseases. This review primarily uses diethylstilbestrol (DES) as a model agent for EDCs and discusses the recent progress elucidating how DES and other EDCs affect murine female reproductive tract development and cancer at the molecular level.

Indexed as

Prenatal Exposure Delayed EffectsAnimalsDiethylstilbestrolEndocrine DisruptorsFemaleGenitalia, FemaleHumansMiceMullerian DuctsPregnancyDiethylstilbestrolEndocrine Disruptors

Identifiers

PMID19709900
PMCPMC2774851
OpenAlexW1967295348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.